Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1994-3-24
|
| pubmed:abstractText |
In recent years many therapeutic regimens have been designed in order to improve response rate and response duration in non-Hodgkin's lymphoma (NHL). In 1991 the Italian Lymphoma Study Group (GISL) started a prospective randomized trial on treatment of aggressive and advanced NHL, focused on the efficacy of two Pro-MACE-CytaBom (P-C) derived protocols.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0390-6078
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
78
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
N
|
| pubmed:pagination |
306-12
|
| pubmed:dateRevised |
2010-3-24
|
| pubmed:meshHeading |
pubmed-meshheading:8314160-Adolescent,
pubmed-meshheading:8314160-Adult,
pubmed-meshheading:8314160-Aged,
pubmed-meshheading:8314160-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8314160-Epirubicin,
pubmed-meshheading:8314160-Humans,
pubmed-meshheading:8314160-Idarubicin,
pubmed-meshheading:8314160-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8314160-Middle Aged,
pubmed-meshheading:8314160-Prospective Studies
|
| pubmed:articleTitle |
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial.
|
| pubmed:affiliation |
Dipartimento di Ematologia, Ospedali Riuniti, Regio Calabria.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|